The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic.
The Manhattan-based drugmaker and the German biotech firm became the first pharmaceutical outfits to reveal successful data from a large, late-stage study of a COVID-19 vaccine at a time when the US and other nations are grappling with surging infection counts.
“Today is a great day for science and humanity,” Pfizer CEO Albert Bourla said in a statement. “With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis.”
This data comes from their Phase 3 study.
Pfizer Inc. teamed up with BioNTech SE, and they announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection.
Without Trump easing regulations and forming business-government partnerships, none of this would have happened.
Do you notice that they waited until a week after the election to make the announcement? They didn’t know this last week or two weeks ago?
Subscribe to the Daily Newsletter
